Q4 2024 · 13F-HR
Euclidean Capital LLCholdings as filed
Filed 2025-02-14 · accession 0001012975-25-000088
$736.7M
Reported value
11
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $525.3M | 71.3% | 896,254 | Common | SOLE |
| 46429B598 | INDA | ISHARES TR | $127.7M | 17.3% | 2,425,144 | Common | SOLE |
| 922042775 | VEU | VANGUARD INTL EQUITY INDEX F | $58.2M | 7.90% | 1,013,434 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $8.0M | 1.08% | 989,410 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $7.4M | 1.01% | 1,573,761 | Common | SOLE |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS INC | $4.0M | 0.54% | 2,627,643 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $2.5M | 0.34% | 1,307,858 | Common | SOLE |
| 87990A106 | TNYA | TENAYA THERAPEUTICS INC | $1.5M | 0.20% | 1,015,705 | Common | SOLE |
| 86889P208 | SRZN | SURROZEN INC | $1.3M | 0.17% | 87,696 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $1.0M | 0.14% | 657,899 | Common | SOLE |
| 86889P117 | SRZNW | SURROZEN INC | $3,656 | 0.00% | 170,833 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.